Coloplast A/S (OCSE:COLO B) Other Gross PPE : kr6,319 Mil (As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Coloplast A/S Other Gross PPE?

Coloplast A/S's Other Gross PPE for the quarter that ended in Mar. 2024 was kr6,319 Mil.

Coloplast A/S's quarterly Other Gross PPE increased from Sep. 2023 (kr0 Mil) to Dec. 2023 (kr6,073 Mil) and increased from Dec. 2023 (kr6,073 Mil) to Mar. 2024 (kr6,319 Mil).

Coloplast A/S Other Gross PPE Historical Data

The historical data trend for Coloplast A/S's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast A/S Other Gross PPE Chart

Coloplast A/S Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Other Gross PPE

Get a 7-Day Free Trial

615.00

Coloplast A/S Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Gross PPE	Get a 7-Day Free Trial															5,617.00	5,793.00	-	6,073.00	6,319.00

Coloplast A/S Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Coloplast A/S (OCSE:COLO B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast A/S (OCSE:COLO B) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

CLPBY:USA CLPBF:USA COLOBc:UK 0QBO:UK CBHD:Germany

Address

Holtedam 1-3, Humlebaek, DNK, DK-3050

Website

https://www.coloplast.com

Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast A/S (OCSE:COLO B) Headlines

No Headlines